Skip to content
A3374Assembly2023-2024 SessionSame asS5704

Limit Antipsychotics for Dementia

Official title

“Limits the off label use of antipsychotic drugs on elderly patients with dementia”

Sponsor Alicia HyndmanAD-29Affects Health
Status
In Assembly Committee
Health
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill restricts off-label use of antipsychotic drugs with black box warnings for elderly dementia patients and establishes professional misconduct penalties for violations.

Why it matters

  1. Protects elderly dementia patients from unnecessary or risky medication. The bill specifically targets the off-label use of strong antipsychotics with FDA black box warnings, which are associated with serious or fatal side effects in this vulnerable population.

  2. Limits use of antipsychotics to true emergencies by qualified professionals. Only health care professionals with specialized dementia training can prescribe these drugs to dementia patients—and only in emergency situations where safety is at risk—helping prevent misuse as a form of chemical restraint.

  3. Increases transparency and accountability in care. The legislation mandates immediate documentation and notification to the patient’s representative and family whenever such a drug is administered, making it harder to medicate patients without oversight.

  4. Establishes clear legal consequences for violations. Health care providers who break these rules can be found guilty of professional misconduct, which could lead to disciplinary action, loss of license, or other penalties, adding significant enforcement power to the law.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Limit Antipsychotics for Dementia

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Alicia Hyndman

Assembly Member · Assembly District 29

Chair, Higher Education

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S5704Senate

Limit Antipsychotics for Elderly

In Senate Committee · Health · Sponsor Leroy Comrie

Impact 7 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

3374

2023-2024 Regular Sessions

IN ASSEMBLY

February 2, 2023

Introduced by M. of A. HYNDMAN -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to limiting the off label use of antipsychotic drugs with black box warnings on elderly patients with dementia; and to amend the education law, in relation to professional medical misconduct

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 280-d to read as follows:

§ 280-d. Use of antipsychotic drugs on elderly patients with dementia. 1. As used in this section:

(a) "off label" means a medical practice in which a physician prescribes a drug for a different medical purpose than the one for which such drug is approved for;

(b) "black box warning" means a warning issued by the federal Food and Drug Administration and placed on the package insert of a prescription drug that may be fatal or cause server side effects;

(c) "chemical restraint" means when an antipsychotic drug that provides no medical benefit to a patient with dementia and is used to sedate such patient, control such patient's behavior or restrict such patient's movement;

(d) "antipsychotic drug" means any typical or atypical antipsychotic drug that is intended to be used on patients with mental illness that require a black box warning and shall include but not be limited to the following:

(i) Typical antipsychotic drugs: haloperidol, loxapine, thioridazine, molindone, thiothixene, fluphenazine, trifluoperazine, chlorpromazine, perphenazine, or promozide; or

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD04705-01-3

(ii) Atypical antipsychotic drugs: aripiprazole, lumapeterone, clozaril, iloperidone, ziprasidone, paliperidone, lurasidone, brexipiprazole, risperidone, asenapine, quetiapine, cariprazine, or olanzapine; and

(e) "patient" means an elderly individual with dementia who is:

(i) a resident of a residential health care facility as defined in article twenty-eight of this chapter or an adult care facility certified under section four hundred sixty-one-b of the social services law; or

(ii) in the care of a hospital as defined in article twenty-eight of this chapter, a facility as defined in article twenty of this chapter or any other health care facility who care for individuals with dementia.

2. No antipsychotic drug that contains a black box warning shall be used for an off label purpose on a patient known to have dementia or to chemically restrain a patient known to have dementia. An order for an antipsychotic drug may only be issued in an emergency situation and by a health care professional who specializes in dementia or is specifically trained in the treatment of dementia patients if such a patient is agitated and where it is reasonably necessary to protect the life, health or safety of the patient or another person. Where an order is made under this subdivision, the health care professional shall immediately record the use of the antipsychotic drug, the reason for the use, and the dosage, in the patient's medical record; and shall promptly notify the patient or the patient's lawful representative who would have had the authority to consent that such drug with a black box warning was used and any family member required to be notified under this section and record such notifications in the patient's medical record.

3. This section does not increase the lawful scope of practice of any health care professional and does not diminish or impair any requirement for or regulation of consent to health care treatment. A health care professional who fails to comply with the provisions of this section may be found guilty of professional misconduct pursuant to article one hundred thirty-one-a of the education law.

4. The commissioner may make rules or regulations to implement the provisions of this section.

§ 2. Section 6530 of the education law is amended by adding a new subdivision 51 to read as follows:

51. Failing to comply with the provisions of section two hundred eighty-d of the public health law.

§ 3. This act shall take effect on the thirtieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.